STEAP4 and posterior cortical atrophy: To validate the presence of STEAP4+ myoCAF in PCa patients, we applied flow cytometry to seperate STEAP4+ myoCAF from tumor tissue (Figure 1H) and validated the isolation of STEAP4+ myoCAF by immunofluorescence (Figure S1E, Supporting Information).